Orange Book product · Generic (ANDA)
MYTREX A
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
At a glance
May 23, 1986
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 23, 1986
40 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
Strength
EQ 3.5MG BASE/GM;0.1%
Dosage form
OINTMENT
Route
TOPICAL
TE code
Not listed
Application
ANDA 062609
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE
- 1986MYTREX AGeneric (ANDA)
ANDA 062598 · SAVAGE LABS
- 1986NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 062600 · FOUGERA
- 1986NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 062595 · PHARMADERM
- 1986NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 062608 · FOUGERA
- 1986NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDEGeneric (ANDA)
ANDA 062607 · PHARMADERM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
